AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) — Stella

Recruiting

Back to Fertility Preservation trials

Trial locations(10 sites)

Belgium

Centre Hospitalier Chrétien (CHC)- Clinique de l'espérance, Montegnée, Liège

Universitair Ziekenhuis Antwerpen, Antwerp

Hôpital Universitaire Reine Fabiola (HUDERF), Brussels

Universitair Ziekenhuis Brussels, Brussels

UZ-Gent, Ghent

Key details

Sponsor

Erasme University Hospital

Collaborators

Queen Fabiola Children's University Hospital

Enrollment target

~275 participants

Started

April 2014

Primary completion

December 2021

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

3 Years – 14 Years

Sex

Female only

Last updated May 2020

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov